000 01509nam  2200361zi 4500
0019.907043
003CaOODSP
00520221107181301
006m     o  d f      
007cr |||||||||||
008220118t20172022onc     ob   f000 0 eng d
020 |a9780660416854
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH139-35/2022E-PDF
24500|aGuide to reporting drug shortages and discontinuations.
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cMarch 14, 2017.
264 4|c©2022
300 |a1 online resource (23 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Guide pour la déclaration de pénuries et de cessations de la vente de drogues.
500 |a"GUI-0120."
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references.
650 0|aDrug accessibility|zCanada.
650 0|aDrug accessibility|xLaw and legislation|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tGuide pour la déclaration de pénuries et de cessations de la vente de drogues.|w(CaOODSP)9.907044
85640|qPDF|s1.47 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H139-35-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/drugs-health-products/reporting-drug-shortages-discontinuations.html